Dr. Taimoor Adnan, MD

Dr. Adnan practices at Ohio State University Hospital in Columbus, Ohio, part of The Ohio State University Wexner Medical Center.

Dr. Adnan's NPI, 1225481088, was assigned on July 18, 2016. Dr. Adnan holds Ohio license 35.135084.

Dr. Adnan's primary practice is Ohio State University Hospital, at 410 West 10th Avenue, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-9700.

Dr. Adnan's primary practice is Ohio State University Hospital in Columbus, Ohio, part of The Ohio State University Wexner Medical Center. Dr. Adnan is also affiliated with The James Cancer Hospital and Solove Research Institute. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Adnan to 3 more hospitals, 2 hospital outpatient departments and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adnan practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Adnan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Adnan is licensed in Ohio.

CMS data shows 373 Medicare services from Dr. Adnan across 10 procedure codes in 2024, for 165 Medicare patients. Medicare paid $31,383 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Adnan in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adnan's median patient age at 67, with 49% women.

In 2024, Dr. Adnan wrote 307 Medicare Part D claims for 122 patients. 88% of them were for generic drugs. CMS names the drug for 110 of them, across 7 drugs with 11 or more claims each, at $9,666 in total drug cost. In 2023, CMS named 72 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Adnan for performance year 2024, reported as part of a group. Dr. Adnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 51 general payments to Dr. Adnan from 9 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $372.